You are here: Fairness.com > Resources > High Stakes for Merck in Litigation...

High Stakes for Merck in Litigation on Fosamax

Date: September 2, 2009

Author: Natasha Singer

QUOTE: Drug executives, product liability lawyers and Wall Street analysts are closely watching a jury trial in New York over medical problems associated with Fosamax, a drug from Merck... It is the first of about 900 state and federal cases pending against Merck in which plaintiffs claim that taking Fosamax caused them to develop a rare problem called osteonecrosis of the jaw.

• Read it: New York Times
• Tell a friend
• Add a Comment*

Article MetaInformation:

Key People:

Key Organizations:

• Food and Drug Administration (FDA)
• Merck & Co.
• New York Times Company
• Schering-Plough Corporation

Subject & Geographic Categories:

• Abstract Principles
  • Control / Access / Permission
    • Choices/Tolerance/Flexibility
    • Principles / Guidelines / Rules / Policy
  • Information
    • Measurement
      • Standards
    • Truth / Honesty / Lying / Cheating
      • Hide/Mislead

• Businesses & Organizations
  • Sales & Marketing
    • Marketing
      • PR / Public Relations

• Health & Medicine
  • Health Care Business
    • Pharmaceutical / Drug / Biotech
  • Medical Ethics
  • Testing (Medical/Genetic)

• Law & Justice
  • Civil Law / Common Law
    • Lawsuits / Litigation

• North America
  • United States of America/USA

Comments:

none

• Add a Comment*

*User comments are posted without Fairness.com LLC's prior review or approval, and Fairness.com LLC takes no responsibility for them; please see our Conditions of Service Agreement.

Please send your comments and suggestions to the Webmaster. © copyright 1999-2009, Fairness.com LLC.
"Fairness.com" and "Life isn't fair... but we're working on it" are service marks of Fairness.com LLC. All rights reserved.